Xeljanz Vs Humira Adalimumab Rheumatoid Arthritis Treatment

 

xeljanz vs humira

Humira is a TNF-alpha inhibitor that can be used to treat a variety of inflammatory conditions including rheumatoid arthritis, psoriasis, ankylosing spondylitis, Crohn's disease, and ulcerative colitis. Humira can impair your immune system's ability to combat infections caused by bacteria, fungi, or viruses. It may also increase your chances of developing certain cancers.

Prescribed for Rheumatoid Arthritis, Ankylosing Spondylitis, Ulcerative Colitis, Atopic Dermatitis, Psoriatic Arthritis, and Non-Radiographic Axial Spondyloarthritis, on the other hand.

 

Xeljanz (tofacitinib citrate), on the other hand, is a Janus kinase (JAK) inhibitor that is used to treat adults with moderate to severe active rheumatoid arthritis (RA) who have not responded to or cannot tolerate methotrexate.
Xeljanz (tofacitinib citrate) is a Janus kinase (JAK) inhibitor used to treat rheumatoid arthritis.. Xeljanz is an oral medication that works differently from the injectable medications and Enbrel to lessen joint pain and swelling caused by rheumatoid arthritis.
. Long-term safety studies have shown that Xeljanz may raise your risk of developing serious heart problems and cancer more than Enbrel.